HIGHLIGHTS
- who: u041eu0411u0417u041eu0420u042b u041bu0418u0422u0415u0420u0410u0422u0423u0420u042b and collaborators from the EAMedical University, Russia. have published the Article: u0420u0438u0441u043a u0440u0430u0437u0432u0438u0442u0438u044f u0445u0440u043eu043du0438u0447u0435u0441u043au043eu0439 u0441u0435u0440u0434u0435u0447u043du043eu0439 u043du0435u0434u043eu0441u0442u0430u0442u043eu0447u043du043eu0441u0442u0438 u0443 u0431u043eu043bu044cu043du044bu0445 u0441u0430u0445u0430u0440u043du044bu043c u0434u0438u0430u0431u0435u0442u043eu043c 2 u0442u0438u043fu0430, u043fu043eu043bu0443u0447u0430u044eu0449u0438u0445 u0442u0435u0440u0430u043fu0438u044e u0438u043du0441u0443u043bu0438u043du043eu043c: u043cu0435u0442u0430u0430u043du0430u043bu0438u0437 u043du0430u0431u043bu044eu0434u0430u0442u0435u043bu044cu043du044bu0445 u0438u0441u0441u043bu0435u0434u043eu0432u0430u043du0438u0439 Risk of heart failure in patients with type 2 diabetes receiving insulin therapy: a meta-analysis of observational studies, in the Journal: (JOURNAL)
SUMMARY
Meta-analysis demonstrated a high heterogeneity of studies, which indicates the need for randomi zed clinical trials that will correctly analyze the com parison of modern insulins and hypoglycemic agents from the standpoint of heart failure risk . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.